[Drug-induced pancreatitis].
Kozu
Tadahiko
T
Tokyo Women's Medical University.
D000890:Anti-Infective Agents / Q000009:adverse effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D001379:Azathioprine / Q000009:adverse effects; D002317:Cardiovascular Agents / Q000009:adverse effects; D016049:Didanosine / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D010195:Pancreatitis / Q000139:chemically induced* / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D011619:Psychotropic Drugs / Q000009:adverse effects; D012015:Reference Standards; D013997:Time Factors; D014635:Valproic Acid / Q000009:adverse effects
D000890:Anti-Infective Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D002317:Cardiovascular Agents; D011619:Psychotropic Drugs; D014635:Valproic Acid; D016049:Didanosine; D001379:Azathioprine